more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$327.48 USD

-3.64 (-1.10%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth A Momentum B VGM

Industry Rank:

Bottom 15% (212 out of 249)

Industry: Medical - HMOs

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Molina (MOH) Tops Q2 Earnings Estimates

by Zacks Equity Research Published on July 30,2020

Molina (MOH) delivered earnings and revenue surprises of 1.92% and -1.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MOHNegative Net Change

Will Cigna (CI) Keep the Beat Streak Alive in Q2 Earnings?

by Zacks Equity Research Published on July 29,2020

Cigna's (CI) business is likely to have been weighed down in Q2 due to high unemployment rate, partly offset by the delay in elective procedures resulting in lower claims.

medical

Centene's (CNC) Q2 Earnings Miss Estimates, Revenues Beat

by Zacks Equity Research Published on July 28,2020

Centene's (CNC) second-quarter results reflect robust revenues.

medical

5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus

by Zacks Equity Research Published on July 28,2020

Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.

medical

Anthem (ANTM) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research Published on July 27,2020

Anthem's (ANTM) second-quarter results are likely to reflect impressive revenues and rising membership.

medical

What's in the Cards for Centene's (CNC) Q2 Earnings?

by Zacks Equity Research Published on July 24,2020

Centene's (CNC) Q2 results are likely to reflect better revenues, partly offset by the COVID-19 impact.

medical

Universal Health (UHS) to Report Q2 Earnings: What to Expect

by Zacks Equity Research Published on July 23,2020

Universal Health's (UHS) second-quarter results are likely to reflect muted revenues.

Molina (MOH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research Published on July 23,2020

Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MOHNegative Net Change

HCA Healthcare's (HCA) Q2 Earnings Beat Estimates, Fall Y/Y

by Zacks Equity Research Published on July 22,2020

HCA Healthcare's (HCA) second-quarter results reflect lower expenses, partly offset by a decline in admissions.

Should Value Investors Buy Molina (MOH) Stock?

by Zacks Equity Research Published on July 21,2020

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MOHNegative Net Change

Molina Healthcare's Buyout Deal to Boost Its Base in Kentucky

by Zacks Equity Research Published on July 21,2020

Molina Healthcare's (MOH) upcoming acquisition will fortify its presence in the Kentucky market.

medical

Humana Ties Up With DCI's Affiliate to Serve Members With CKD

by Zacks Equity Research Published on July 21,2020

Humana (HUM) ties up with DCI and its affiliate REACH Kidney Care to offer improved health outcomes for CKD patients in Alabama, North Carolina, South Carolina, and Tennessee.

medical

Quest Diagnostics (DGX) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research Published on July 17,2020

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

UnitedHealth's Unit Ties Up With Boulder Community Health

by Zacks Equity Research Published on July 15,2020

UnitedHealth's (UNH) Optum reaches an agreement with Boulder Community Health to provide better medical services to communities in the Boulder County as well as its surroundings.

medical

Why You Should Add Molina Healthcare (MOH) to Your Portfolio

by Zacks Equity Research Published on July 15,2020

Riding high on its strategic initiatives and a solid top line, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.

medical

UnitedHealth's (UNH) Earnings in Q2 Beat on Lower Payouts

by Zacks Equity Research Published on July 15,2020

UnitedHealth's (UNH) Q2 earnings outperformance is driven by a temporary postponement of care in the company's risk-based businesses amid the plaguing pandemic .

medical

6 Health Insurance Stocks Poised to Beat on Earnings in Q2

by Sapna Bagaria Published on July 13,2020

Health insurers' second-quarter 2020 earnings results are likely to gain from lower healthcare utilization, partly offset by higher costs.

medical

Q2 Earnings Likely To Plunge: Invest in These Sector ETFs

by Sweta Killa Published on July 08,2020

Earnings growth is expected to be negative for 15 of the 16 Zacks sectors with double-digit declines.

3 Health Insurers Poised for a Bull Run in the Second Half

by Srijita Guha Published on July 07,2020

We shortlist three health insurance stocks for the second half of 2020 that should enhance your portfolio, given their solid fundamentals.

medical

5 Reasons That Make Cigna (CI) an Attractive Stock to Own

by Zacks Equity Research Published on July 06,2020

Acquisitions, business streamlining, strong balance sheet, high profitability, clear visibility of earnings growth make Cigna (CI) and attractive bet.